Pharmacia & Upjohn CEO search to replace Zabriskie comes as company is riding NDA approval wave.
Executive Summary
PHARMACIA & UPJOHN CEO SEARCH LIKELY TO FOCUS ON OUTSIDERS to replace John Zabriskie, PhD, as chief executive officer of the newly merged firm. Former Pharmacia CEO Jan Ekberg has stepped down as non-executive chairman of Pharmacia & Upjohn to serve as interim CEO. Appointment of an outsider as permanent CEO could avoid internal tensions about the ascendancy of Pharmacia or Upjohn in the "merger of equals" while reassuring the financial community that the integration process is being overseen by an objective eye.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth